- Home
- Products
Zemdri (Plazomicin)
Zemdri (Plazomicin)
- Medicine Name: Zemdri
- Generic Name: Plazomicin
- Dosage Form & Strength: Injection – 500 mg/10 mL (50 mg/mL)
- Manufactured By: Achaogen, Inc.
Zemdri (Plazomicin) is a next-generation aminoglycoside antibiotic used to treat complicated urinary tract infections (cUTIs), including pyelonephritis in adults caused by:
- Escherichia coli
- Klebsiella pneumoniae
- Enterobacter cloacae
- Proteus mirabilis
It is particularly used for infections resistant to conventional antibiotics.
Recommended Dosage:
- 15 mg/kg IV infusion over 30 minutes once daily
- Duration: up to 7 days, depending on clinical condition
- Dose adjustment required for patients with renal impairment
Kidney Function: Risk of nephrotoxicity. Monitor creatinine clearance before and during treatment.
Hearing Loss: Ototoxicity (hearing loss, tinnitus, vertigo) may occur. Avoid in those with prior hearing issues or renal impairment.
Neuromuscular Effects: May worsen symptoms in patients with neuromuscular disorders.
Pregnancy Risk: May cause fetal harm. Avoid use in pregnant women.
Allergic Reactions: Risk of severe hypersensitivity. Check for history of aminoglycoside allergies.
C. difficile-associated Diarrhea: Discontinue treatment if suspected.
Antibiotic Resistance: Use only when a bacterial infection is confirmed or strongly suspected.
To import Zemdri (Plazomicin) to India, the following documents are required:
- Valid prescription from a qualified doctor
- Diagnostic reports
- Government-issued ID proof
📦 Availability:
Available in major Indian cities including Delhi, Mumbai, Hyderabad, Chennai, Kolkata, Bangalore, Pune, Ahmedabad, and across South Asia.
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds ensures:
- Ethical sourcing of Zemdri from verified suppliers in the USA, Europe, Canada, and Australia
- Fast and secure shipping from our fulfillment center in Ambernath, Thane District
- Dispatch only after prescription verification by certified pharmacists
- Transparent process with dedicated customer support
Q: What is Zemdri used for?
A: It is used for treating complicated urinary tract infections (cUTIs) including pyelonephritis in adults.
Q: What is the strength and form of Zemdri?
A: Zemdri is supplied as an intravenous injection – 500 mg/10 mL (50 mg/mL).
Q: Who manufactures Zemdri?
A: Zemdri is manufactured by Achaogen, Inc.
Q: Is Zemdri FDA approved?
A: Yes. Zemdri was approved by the FDA on June 25, 2018.
Q: What are the most common side effects?
A: Nausea, vomiting, diarrhea, decreased renal function, hypotension, headache, and elevated blood pressure.
Q: How should Zemdri be stored?
A: Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze.
Q: Where can I buy Zemdri in India?
A: You can buy it via GlobalRareMeds.com with a valid prescription. Contact us for assistance.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
